Merck has announced further support for Australia's Multiple Sclerosis (MS) community with a new research scholarship to help fund neurology research at the Royal Melbourne Hospital. [ + ]

The Perron Institute for Neurological and Translational Science has welcomed Emeritus Professor Alan Robson AO CitWA as its new board chair. [ + ]

Australian researchers have taken part in a study seeking to spread the bacteria Wolbachia, which reduces the capacity of insects to transmit viruses, in urban mosquito populations. [ + ]

Nominations have opened for the AusBiotech and Johnson & Johnson Industry Excellence Awards, to be presented at AusBiotech 2017 on 25 October. [ + ]

ANSTO researchers have been using X-ray imaging on the feathers of long-distance migratory seabirds. The results of their study could lead to important new insights into the evolution and health of birds. [ + ]

UK researchers have made a breakthrough in understanding how different genetic mutations cause acute myeloid leukaemia (AML) — one of the most common acute leukaemias in adults. [ + ]

US researchers have discovered a biochemical signalling process that causes densely packed cancer cells to break away from a tumour and spread the disease elsewhere in the body. [ + ]

Scientists have created designer viruses that alert the immune system and cause it to send killer cells to help fight cancer. [ + ]

The city of Brisbane has become home to what is claimed to be the world's most advanced genomics sequencer. [ + ]

ANSTO, the Centre for Medical Radiation Physics at the University of Wollongong and the National Institute of Radiological Sciences (NIRS), Japan, have partnered to deliver advanced cancer treatment, based on carbon ion therapy. [ + ]

Dr Amali Mallawaarachchi has been awarded a grant by PKD Foundation Australia to support the development of an improved genomic diagnostic tool for individuals with kidney disease. [ + ]

Japanese researchers have reported the effect of a particular type of monoclonal antibody on epilepsy in mice, with promising results. [ + ]

Actinogen Medical has recruited and treated the first patient as part of its Phase II clinical trial of Xanamem, the biotech company's cortisol-blocking drug. [ + ]

Researchers have uncovered a novel mechanism behind excessive platelet production present in people with diabetes, placing them at increased risk of cardiovascular complications such as heart attack and stroke. [ + ]

The Australian Academy of Science has inducted 21 of Australia's best scientists for their outstanding contributions to science. [ + ]